What We Do

Brexit and The Industrial Strategy

Following the country’s decision to leave the EU, ABHI has worked to ensure the MedTech position on Brexit has been clearly communicated.

From the outset, we have had an extremely high level of engagement with Ministers and officials, highlighting the importance of the MedTech sector and the implications of various Brexit scenarios.

Both Peter Ellingworth, ABHI Chief Executive and Neil Mesher, ABHI Board Member, Phillips UK sit on the Life Sciences Industrial Strategy Board that was created under the leadership of Professor Sir John Bell to identify the opportunities for our sector as part of the Government’s broader industrial strategy.

After discussions with members and stakeholders we developed our report ‘Healthy Outside the EU’ as our substantive input into both Brexit negotiations and the Industrial Strategy.

Our robust relationships and recommendations on Brexit issues, such as regulation, trade and manufacturing, give our industry a clear and coherent voice across our diverse range of stakeholders and clear input into the Industrial Strategy.

This series of recommendations outlines how the UK can best forge successful international relationships, increase efficiency of healthcare delivery and improve patient outcomes.

Top Priorities 

ABHI consultation with Members has brought together five recommendations that represent a clear view for UK MedTech:

1. Ensuring regulatory stability and leveraging the global reputation of UK regulators

2. Maintaining favourable terms for trading within and outside the EU, along with an integrated domestic policy to support investment, competitiveness and export performance

3. Support for manufacturing, including continuing to address the domestic skills gap and ensuring that the UK can attract the best talent globally

4. Bespoke support for our vibrant SME community

5. Enhanced collaboration with the health and care system.

How to Get Involved 

Join the ABHI Public Affairs Policy Group (ABHI Members-only)

Sign up for email updates via our home page to receive regular updates on Brexit and the EU negotiations as well as invites to events and webinars (ABHI Members-only).

Give us your views - We are continually seeking the views of ABHI Members on Brexit. Contact us to let us know your views or arrange a call or meeting.

Resources & Timeline of our Engagements

House of Commons Exiting the European Union Committee - Life Sciences Sector Report 05/01/2018

Article 50 negotiations between the European Union and the United Kingdom (Brexit) Position Paper  09/11/2017

UK Government Position Papers and Future Partnership Papers Updated 18/09/2017

Joint MedTech Associations Letter to Michel Barnier & Rt. Hon David Davis MP 12/09/2017

NHS Employers Brexit podcast, featuring ABHI's Richard Phillips 09/09/2017 

12 point Brexit Checklist from Scottish Enterprise 31/08/2017

Press Release: BHA Warns Patients at Risk in Brexit Negotiations 01/08/2017

ABHI Brexit Recommendations Framework 19/07/2017 

ABHI briefing on the European Withdrawal Bill 19/07/2017

A Blog on the EU Withdrawal Bill from Alison Dennis, Chair of our Legal Issues and Compliance Committee 17/07/2017

Press Release: Manufacturing Costs and a Challenging NHS Concern MedTech 07/07/2017

ABHI Brexit Survey Results 2017 07/07/2017

Politics, Policy, Business and Brexit - What Next for MedTech: Speakers Notes 28/06/2017 

ABHI Joins Brexit Health Alliance 16/06/2017

Member Consultation Response 13/04/2017

Healthy Outside the EU Published: 04/04/2017

Member Consultation: Industrial Strategy Input  10/01/2017

ABHI Joins New Life Sciences Industrial Strategy Board 30/11/2016

Press Release: Brexit - Key Messages 15/07/2016

Pre-referendum Members survey results 23/05/2016